You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed Solid Tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSX01-TCRT injection)

Recruiting
  • TCR-T Cells
  • +2 more
  • KSX01-TCRT injection
  • Nanning, Guangxi Zhuang Autonomous Region, China
    The first affiliated hospital of Guang Xi medical university
Mar 31, 2023

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023

TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSH01 injection)

Recruiting
  • TCR-T Cells
  • +2 more
  • KSH01 injection
  • Nanning, Guang XI, China
    The first affiliated hospital of Guang Xi medical university
Sep 14, 2022

Solid Tumors Trial run by the National Cancer Institute (NCI) (Nilotinib + Paclitaxel)

Recruiting
  • Solid Tumors
  • Nilotinib + Paclitaxel
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023

Tumors, Lymphoma Trial run by the National Cancer Institute (NCI) (LMP400, LMP776)

Completed
  • Neoplasms
  • Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022

Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)

Not yet recruiting
  • Relapsed or Refractory Lymphomas
  • Advanced Solid Tumor
  • Los Alamitos, California
    Cancer and Blood Specialty Clinic
Nov 9, 2023

Relapsed Solid Tumor, Refractory Cancer, Solid Tumor, Adult Trial (STI-3258)

Withdrawn
  • Relapsed Solid Neoplasm
  • +2 more
  • STI-3258
  • (no location specified)
Jan 24, 2023

Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor Trial (TR115)

Not yet recruiting
  • Non-Hodgkin's Lymphoma, Relapsed
  • +2 more
  • (no location specified)
Dec 6, 2022

Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,

Not yet recruiting
  • Solid Tumors
  • +8 more
  • Magnetic Resonance-Guided High Intensity Focused Ultrasound
  • Lyso-thermosensitive Liposomal Doxorubicin
  • (no location specified)
Mar 10, 2022

Relapsed Solid Tumors, Refractory Solid Tumors Trial in Aurora, Lexington, Dallas (Eribulin, Irinotecan, Cefixime)

Completed
  • Relapsed Solid Tumors
  • Refractory Solid Tumors
  • Aurora, Colorado
  • +2 more
Jan 31, 2022

Solid Tumor Trial in Taichung (HLA-G-CAR.BiTE allogeneic ?d T cells)

Not yet recruiting
  • Solid Tumor
  • HLA-G-CAR.BiTE allogeneic γδ T cells
  • Taichung, Non-US, Taiwan
    China Medical University Hospital
Nov 27, 2023

Solid Tumor Trial in Houston (IMGS-001)

Recruiting
  • Solid Tumor
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2023

Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)

Recruiting
  • Lymphoma, Solid Tumors
  • Mitoxantrone Hydrochloride Liposome
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2022

Cancer, Cancer of Pancreas, Sarcoma Trial (STI-1386)

Not yet recruiting
  • Cancer
  • +4 more
  • (no location specified)
Dec 15, 2022

Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

Not yet recruiting
  • Solid Tumor
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Aug 30, 2022

Relapsed Solid Tumors, Refractory Solid Tumors, Relapsed Leukemia Trial in Canada, United States (Carfilzomib, Cyclophosphamide,

Recruiting
  • Relapsed Solid Tumors
  • +3 more
  • Phoenix, Arizona
  • +7 more
Apr 12, 2022

Solid Tumors, Adult, Multiple Myeloma, Lymphoma Trial in San Antonio (VP301)

Recruiting
  • Solid Tumors, Adult
  • +2 more
  • San Antonio, Texas
    NEXT Oncology
Jan 16, 2023

Advanced Solid Tumors, Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Multiple Myeloma Trial in Gyeonggi-do,

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • GIC-102 (Allogeneic NK cells)
  • Gyeonggi-do, Korea, Republic of
  • +3 more
May 18, 2023

Solid Tumor Metastatic Cancer Advanced Cancer Trial (TJ210001)

Available
  • Solid Tumor Metastatic Cancer Advanced Cancer
  • (no location specified)
Aug 19, 2022

Advanced Solid Tumors, Relapsed Or Refractory Non-Hodgkin Lymphoma Trial in Zhengzhou, Hangzhou (YH004)

Not yet recruiting
  • Advanced Solid Tumors
  • Relapsed Or Refractory Non-Hodgkin Lymphoma
  • Zhengzhou, Henan, China
  • +1 more
Oct 20, 2022

Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)

Not yet recruiting
  • Advanced Solid Tumor
  • Refractory Non-Hodgkin Lymphoma
  • (no location specified)
May 28, 2023

Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • CTX131
  • Nashville, Tennessee
    Research Site 1
Mar 21, 2023

Solid Tumors Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion)

Recruiting
  • Solid Tumors
  • microtransplantation, HLA-mismatched donor peripheral stem cell infusion
  • Beijing, Beijing, China
    Beijing Fengtai You'anmen Hospital
Jun 16, 2021

Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

Recruiting
  • Lung Cancer
  • +11 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Anqing, Anhui, China
    The PLA Navy Anqing Hospital
May 23, 2023